Opioid overdose rates 'impossible' to ignore

November 21, 2012 by Jason Kornwitz

(Medical Xpress)—Opioid over­dose now kills more people than both AIDS and homi­cides in America and has sur­passed auto­mo­bile acci­dents as the leading cause of acci­dental death in many states. According to the Cen­ters for Dis­ease Con­trol and Pre­ven­tion, the bur­geoning epi­demic accounts for approx­i­mately 16,000 deaths per year in the U.S.

"No one was talking about this problem a few years ago," said Leo Beletsky, a drug policy expert and assis­tant pro­fessor of law and health sci­ences at North­eastern Uni­ver­sity, "but it has now become impos­sible for public health and law enforce­ment offi­cials to ignore."

In an article pub­lished ear­lier this month in the Journal of the American Med­ical Association, Beletsky and physician-​​researchers Josiah Rich and Alexander Y. Walley called upon fed­eral agen­cies to take lead­er­ship in addressing this epi­demic through a com­pre­hen­sive series of public health-​​based initiatives.

The trio of researchers posits that the fed­eral government's cur­rent response to the growing public health crisis has focused too nar­rowly on restricting access to pre­scrip­tion and , an approach that has failed to pro­duce results. "We know from decades of expe­ri­ences in sub­stance abuse how dif­fi­cult it is to win bat­tles by focusing too nar­rowly on the 'supply' side of the equa­tion," Beletsky explained. "As things stand, not enough is being done to max­i­mize the oppor­tu­nity of saving lives."

A litany of bar­riers has con­strained the response, he said, including low public aware­ness of the signs of an over­dose; a shortage of Naloxone, an antag­o­nist; and an unaware­ness or unwill­ing­ness on the part of pre­scribers to par­tic­i­pate in over­dose education.

Of the Naloxone shortage, Beletsky said, "Drugs like Naloxone that are cheap, generic and out of patent are more likely to be in shortage because they aren't per­ceived as a pri­ority for man­u­fac­turers." He called atten­tion to the issue in a recent Time Mag­a­zine article in which he was quoted.

In the paper, Beletsky and his col­leagues make more than a dozen rec­om­men­da­tions designed to improve the pre­ven­tion of fatal opioid over­dose. They call upon the National Insti­tutes of Health to eval­uate community-​​based naloxone access ini­tia­tives, for example, and for the Depart­ment of Jus­tice to for­mu­late and dis­sem­i­nate model leg­is­la­tion proving legal immu­nity to pre­scribers and lay respon­ders. They also sin­gled out the U.S. Food and Drug Admin­is­tra­tion, calling on the orga­ni­za­tion to require con­tin­uing edu­ca­tion pro­grams for health­care providers to cover over­dose prevention.

"Fed­eral agen­cies and policy-​​makers can and should take con­crete steps that could go a long way toward addressing this issue," Beletsky said. "We have seen a lot of suc­cessful exper­i­men­ta­tion in over­dose pre­ven­tion on the local and state level and now it is time for the fed­eral level to take the lead."

Explore further: Eating your fruits and veggies

More information: works.bepress.com/leo_beletsky/

Related Stories

Eating your fruits and veggies

August 31, 2012

(Medical Xpress)—Teenagers in gen­eral are rel­a­tively unhealthy eaters. But minority teens in par­tic­ular have higher rates of obe­sity and eat far fewer fruits and vegetables.

3Qs: When painkillers kill

August 3, 2012

The U.S. Food and Drug Admin­is­tra­tion recently intro­duced a series of safety mea­sures designed to reduce the risk of extended-​​release and long-​​acting opioid med­ica­tions, ...

Mental illness and limited literacy

October 8, 2012

(Medical Xpress)—Approx­i­mately 47 per­cent of the U.S. pop­u­la­tion reads below an eighth-​​grade level, but the per­centage is sig­nif­i­cantly greater among people using public mental-​​health ser­vices, ...

3Qs: Many questions remain in meningitis outbreak

October 18, 2012

In recent weeks, an out­break of fungal menin­gitis has infected more than 200 people and killed 15. The infec­tion was traced back to a steroidal injec­tion pre­pared at a com­pounding phar­macy based in Fram­ingham, ...

Recommended for you

Researchers identify source of opioids' side effects

January 17, 2017

A commercially available drug may help drastically reduce two side effects of opioid painkillers—a growing tolerance and a paradoxical increased sensitivity to pain—without affecting the drugs' ability to reduce pain, ...

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.